Ivermectin Does Not Speed Symptom Resolution in Mild COVID-19
FRIDAY, March 5, 2021 -- A five-day course of ivermectin does not improve the time to resolution of symptoms compared with placebo for adults with mild COVID-19, according to a study published online March 4 in the Journal of the American Medical Association.
Eduardo López-Medina, M.D., from the Universidad del Valle in Cali, Colombia, and colleagues randomly assigned 400 adult patients with mild COVID-19 and symptoms for seven days or fewer to receive either ivermectin for five days (200 patients) or placebo (200 patients). Patients were enrolled between July 15 and Nov. 30, 2020, and were followed through Dec. 21, 2020.
The researchers found that the median time to resolution of symptoms was 10 and 12 days in the ivermectin and placebo groups, respectively (hazard ratio for resolution of symptoms, 1.07; 95 percent confidence interval, 0.87 to 1.32; P = 0.53). By day 21, 82 and 79 percent of patients in the ivermectin and placebo groups, respectively, had resolved symptoms. Headache was the most common solicited adverse event, reported by 52 and 56 percent of patients given ivermectin and placebo, respectively. Multiorgan failure was the most common serious adverse event and occurred in four patients (two in each group).
"The findings do not support the use of ivermectin for treatment of mild COVID-19, although larger trials may be needed to understand the effects of ivermectin on other clinically relevant outcomes," the authors write.
Several authors disclosed financial ties to the pharmaceutical industry.
© 2021 HealthDay. All rights reserved.
Posted: March 2021
Further Support and Information on COVID-19
Read this next
Here is what the editors at Physician's Briefing chose as the most important COVID-19 developments for you and your practice for the week of April 12 to 16, 2021. This roundup...
FRIDAY, April 16, 2021 -- The United States should support efforts to temporarily waive intellectual property rules so that nations struggling to vaccinate their populations...
FRIDAY, April 16, 2021 -- The COVID-19 death toll in Europe has surpassed 1 million, and it is seeing about 1.6 million new cases each week, a top World Health Organization...
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.